Institution
Osaka International Cancer Institute
Also known as: Osaka Medical Center for Cancer and Cardiovascular Diseases · 大阪国際がんセンター · 大阪府立成人病センター · OMCCCD
- 111running trials
- 62closed trials
- 9,995publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Active, not recruiting
Recruiting
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Recruiting
Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Recruiting
Active, not recruiting
Active, not recruiting
Showing 50 of 111.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer16 recruiting
- Colorectal cancer10 recruiting
- Gastric and oesophageal cancer6 recruiting
- Sarcoma4 recruiting
- Prostate cancer3 recruiting
- Bladder cancer2 recruiting
- Childhood cancers2 recruiting
- Head and neck cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Neuroendocrine tumours2 recruiting
- Pancreatic cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Ovarian cancer1 recruiting
- Thymoma and thymic carcinoma1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Completed
Completed
Completed
A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer
Completed
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Completed
Completed
Completed
Completed
Completed
Completed
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
Completed
Completed
Terminated
Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Showing 50 of 62.
Registry name variants (35)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Osaka International Cancer Institute
Osaka, 541-8567
120 trials
Osaka International Cancer Institute
Osaka, Osaka, 541-8567
10 trials
Osaka International Cancer Institute
Chuo Ku, Osaka 540-0008
4 trials
Osaka International Cancer Institute
Chūōku, 541-8567
3 trials
Contact: Prinicipal Investigator
NCT05101096Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
Osaka International Cancer Institute
Osakashi, Osaka 541-8567
2 trials
Osaka International Cancer Institute (Site 0809)
Osaka, 541-8567
2 trials
Osaka International Cancer Institute (Site 2607)
Osaka, 5418567
2 trials
Osaka International Cancer Institute (Site 4005)
Osaka, 541-8567
2 trials
Osaka International Cancer Institute (Site 4407)
Osaka, 541-8567
2 trials
Osaka Medical Center for Cancer and Cardiovascular Diseases
Osaka, 537-8511
2 trials
Osaka International Cancer Institute
Chuo, Osaka 541-8567
1 trial
Osaka International Cancer Institute - Dermatological Oncology
Osaka, Ôsaka [Osaka] 541-8567
1 trial
Osaka International Cancer Institute
Osaka, Osaka 5418567
1 trial
Osaka International Cancer Institute
Osaka, Osaka 541-8567
1 trial
Osaka International Cancer Institute
Osaka, Osaka 5418567
1 trial
Osaka International Cancer Institute
Osaka, Osaka 5418567
1 trial
Osaka International Cancer Institute
Osaka, Osaka 5418567
1 trial
Osaka International Cancer Institute (Site 0019)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 0084)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 0113)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 0161)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 0355)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 0401)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 0722)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 1161)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 1209)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 1323)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 1602)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 2409)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 2613)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 2617)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 3018)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 3106)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 3413)
Osaka, 541-8567
1 trial
Osaka International Cancer Institute (Site 9009)
Osaka, 541-8567
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer88 works · 65 trials
- Gastric and oesophageal cancer68 works · 22 trials
- Pancreatic cancer26 works · 6 trials
Institution data: ROR 05xvwhv53 (CC0-1.0)Updated 15 Nov 2026